Clinical Trial Update: Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chemotherapy and radiation therapy with or without vandetanib in high-risk stage III or IV head and neck cancer was terminated. Resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Vandetanib (vandetanib)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-05-08